Goal directed preemptive ephedrine attenuates the reperfusion syndrome during adult living donor liver transplantation

[1]  Hyung‐Chul Lee,et al.  Epinephrine and phenylephrine pretreatments for preventing postreperfusion syndrome during adult liver transplantation , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  T. Reza,et al.  Comparison the effect of ephedrine and phenylephrine in treatment of hypotension after spinal anesthesia during cesarean section , 2012 .

[3]  M. Krawczyk,et al.  The occurrence of postreperfusion syndrome in orthotopic liver transplantation and its significance in terms of complications and short-term survival. , 2011, Annals of transplantation.

[4]  H. Ryu,et al.  Nafamostat Mesilate Attenuates Postreperfusion Syndrome during Liver Transplantation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  K. Mucha,et al.  Evaluation of chronic HCV infection in transplanted livers using a modified histological activity index. , 2011, Annals of transplantation.

[6]  Lucas Cordoví de Armas,et al.  Reperfusão rápida e homogênea como fator de risco da síndrome pós-reperfusão hepática durante transplante ortotópico de fígado , 2010 .

[7]  C. Lombard,et al.  Hemodynamic Effects of Ephedrine, Phenylephrine, and the Coadministration of Phenylephrine with Oxytocin during Spinal Anesthesia for Elective Cesarean Delivery , 2009, Anesthesiology.

[8]  R. Porte,et al.  The clinical relevance of the anhepatic phase during liver transplantation , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  M. Ramsay,et al.  Postreperfusion syndrome during liver transplantation for cirrhosis: Outcome and predictors , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[10]  M. Gwak,et al.  Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than University of Wisconsin solution during the reperfusion period in living donor liver transplantation. , 2008, Transplantation proceedings.

[11]  M. Ramsay.  The reperfusion syndrome: Have we made any progress? , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  A. Marcos,et al.  The impact of postreperfusion syndrome on short‐term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[13]  S. Homer-Vanniasinkam,et al.  Reperfusion Syndrome: Cellular Mechanisms of Microvascular Dysfunction and Potential Therapeutic Strategies , 2007, Vascular and endovascular surgery.

[14]  G. Della Rocca,et al.  Hemodynamics during liver transplantation. , 2007, Transplantation proceedings.

[15]  R. Pradl,et al.  Esophageal Doppler-guided fluid management decreases blood lactate levels in multiple-trauma patients: a randomized controlled trial , 2007, Critical care.

[16]  J. Figueras,et al.  Hemodynamic profile and tissular oxygenation in orthotopic liver transplantation: Influence of hepatic artery or portal vein revascularization of the graft , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  Klaus Görlinger.  [Coagulation management during liver transplantation]. , 2006, Hamostaseologie.

[18]  B. Gridelli,et al.  Comparison of two different techniques of reperfusion in adult orthotopic liver transplantation , 2006, Clinical transplantation.

[19]  J. Henriksen,et al.  Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics , 2006, Gut.

[20]  Kniepeiss Daniela,et al.  Influence of retrograde flushing via the caval vein on the post‐reperfusion syndrome in liver transplantation , 2004, Clinical transplantation.

[21]  D. Reich,et al.  Association of intraoperative hypotension and pulmonary hypertension with adverse outcomes after orthotopic liver transplantation. , 2003, Journal of cardiothoracic and vascular anesthesia.

[22]  Y. Tokat,et al.  Causes of postreperfusion syndrome in living or cadaveric donor liver transplantations. , 2003, Transplantation proceedings.

[23]  J. Findlay,et al.  Aprotinin reduces vasoactive medication use during adult liver transplantation. , 2003, Journal of clinical anesthesia.

[24]  David W. Cooper,et al.  Fetal and Maternal Effects of Phenylephrine and Ephedrine during Spinal Anesthesia for Cesarean Delivery , 2002, Anesthesiology.

[25]  M. Bellamy,et al.  The Effect of Methylene Blue on the Hemodynamic Changes During Ischemia Reperfusion Injury in Orthotopic Liver Transplantation , 2002, Anesthesia and analgesia.

[26]  A. Sheil,et al.  Postreperfusion syndrome in orthotopic liver transplantation. , 2000, Transplantation proceedings.

[27]  H. Putter,et al.  Reduced Need for Vasopressors in Patients Receiving Aprotinin during Orthotopic Liver Transplantation , 2000, Anesthesiology.

[28]  P. Parrilla,et al.  Phenylephrine treatment of the postreperfusion syndrome in liver transplantation. , 1999, Transplantation proceedings.

[29]  M. Vigil,et al.  Response to Clamping of the Inferior Vena Cava as a Factor for Predicting Postreperfusion Syndrome During Liver Transplantation , 1997, Anesthesia and analgesia.

[30]  M. Pinsky,et al.  Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. , 1993, Journal of critical care.

[31]  M. Pinsky,et al.  Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. , 1987, Transplantation proceedings.

[32]  J B Gross,et al.  Estimating allowable blood loss: corrected for dilution. , 1983, Anesthesiology.

[33]  A. Masood,et al.  Optimal dose of prophylactic intravenous ephedrine for spinal-induced hypotension during cesarean section , 2010 .

[34]  R. Jiménez Paneque,et al.  Rapid and homogeneous reperfusion as a risk factor for postreperfusion syndrome during orthotopic liver transplantation. , 2010, Revista brasileira de anestesiologia.

[35]  D. Chestnut.  Hemodynamic Effects of Ephedrine, Phenylephrine, and the Coadministration of Phenylephrine with Oxytocin during Spinal Anesthesia for Elective Cesarean Delivery , 2010 .